BresaGen calls for more time on stem cell laws
05 June, 2002 by Melissa TrudingerStem cell company BresaGen has submitted a position paper to the drafting committee responsible for the forthcoming legislation for use of embryonic stem cells for creation of new stem cell lines for research and development.
HPLC market report: The smaller picture
04 June, 2002 by Melissa TrudingerThe big trend in liquid chromatography instrumentation is the ever-shrinking sample size, according to leading manufacturers of chromatographic instruments.
Now we're a global player: stem cell CEO
03 June, 2002 by Tanya HollisAustralia's decision to back stem cell research with a $46.5 million grant would have international ramifications for local researchers, according to the head of the winning Centre of Excellence bid.
Stem cell opponents shocked by funding decision
31 May, 2002 by Pete YoungOpponents of stem cell research taking part in consultative processes on draft legislation were shocked and surprised by the announcement that the Stem Cells and Tissue Repair consortium had won the Federal government's $46.5 million Centre of Excellence funding.
Stem cell bid wins $46.5m Centre of Excellence funding
31 May, 2002 by Iain ScottA proposal to create a Centre for Stem Cells and Tissue Repair has won a $46.5 million Federal grant to create a national Biotechnology Centre of Excellence.
Draft stem cell laws now out for consultation
28 May, 2002 by Tanya HollisNational legislation on the use of embryonic stem cells in research is on track to be introduced to Parliament next month.
Stem Cell Sciences Alzheimer's test
20 May, 2002 by Tanya HollisMelbourne's Stem Cell Sciences has begun providing pharmaceutical company Aventis with its new test to detect potential Alzheimer's drugs.
Senator calls for transparency in stem cell investment
17 May, 2002 by Tanya HollisAustralians needed to know who was likely to make their fortune through stem cells in order to prioritise information from scientists who may have a vested interest in the research, the Senate has heard.
Aussie stem cells in high demand
16 May, 2002 by Pete YoungResearch institutions are beating a path to the doors of the only two Australian biotechs which supply embryonic stem cells lines meeting current US regulatory requirements.
New labs for Stem Cell Sciences
15 May, 2002 by Tanya HollisMelbourne company Stem Cell Sciences has unveiled new commercial laboratories to produce embryonic stem cells and derivative tissue.
Neural stem cell research could bring Parkinson's cure closer
09 May, 2002 by Tanya HollisMelbourne scientists have become the first in Australia to culture adult neural stem cells, bringing local medicine a step closer to a potential cure for Parkinson's disease.
Agenix revenue record
08 May, 2002 by Pete YoungPublic concern over deep vein thrombosis has helped boost revenues of listed biotech Agenix to a record $29 million in the nine months to March 31.
Import undertakings from Monsanto and Nufarm
07 May, 2002 by Tanya HollisMonsanto and Nufarm have given Australia's consumer watchdog court-enforceable undertakings that they will not try to stop agricultural glyphosate herbicides being imported from China.
Argus makes artificial cornea
01 May, 2002 by Melissa TrudingerIn a major advance for ophthalmology, the Lion's Eye Institute in Perth has developed a flexible, artificial cornea made of hydrogel polymers.
Stem cell production facility for Melbourne
22 April, 2002 by Tanya HollisEmbryonic stem cell research company ES Cell International has received a Victorian government infrastructure grant to set up a stem cell production facility in Melbourne.
